keyword
https://read.qxmd.com/read/38604995/characterization-of-patients-with-ahus-and-associated-triggers-or-clinical-conditions-a-global-ahus-registry-analysis
#1
JOURNAL ARTICLE
Christoph Licht, Imad Al-Dakkak, Katerina Anokhina, Nicole Isbel, Véronique Frémeaux-Bacchi, Rodney D Gilbert, Larry A Greenbaum, Gema Ariceta, Gianluigi Ardissino, Franz Schaefer, Eric Rondeau
INTRODUCTION: Atypical haemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) associated with complement dysregulation; aHUS may be associated with other 'triggers' or 'clinical conditions'. This study aimed to characterize this patient population using data from the Global aHUS Registry, the largest collection of real-world data on patients with aHUS. METHODS: Patients enrolled in the Global aHUS Registry between April 2012 and June 2021 and with recorded aHUS-associated triggers or clinical conditions prior/up to aHUS onset were analysed...
April 11, 2024: Nephrology
https://read.qxmd.com/read/38601560/-cftr-pathogenic-variants-spectrum-in-a-cohort-of-mexican-patients-with-cystic-fibrosis
#2
JOURNAL ARTICLE
Angélica Martínez-Hernández, Elvia C Mendoza-Caamal, Namibia G Mendiola-Vidal, Francisco Barajas-Olmos, José Rafael Villafan-Bernal, Juan Luis Jiménez-Ruiz, Tulia Monge-Cazares, Humberto García-Ortiz, Cecilia Contreras- Cubas, Federico Centeno-Cruz, Carmen Alaez-Verson, Soraya Ortega-Torres, Adriana Del C Luna-Castañeda, Vicente Baca, José Luis Lezana, Lorena Orozco
BACKGROUND: Molecular diagnosis of cystic fibrosis (CF) is challenging in Mexico due to the population's high genetic heterogeneity. To date, 46 pathogenic variants (PVs) have been reported, yielding a detection rate of 77%. We updated the spectrum and frequency of PVs responsible for this disease in mexican patients. METHODS: We extracted genomic DNA from peripheral blood lymphocytes obtained from 297 CF patients and their parents. First, we analyzed the five most frequent PVs in the Mexican population using PCR-mediated site-directed mutagenesis...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38596442/fever-assessment-in-children-under-five-are-we-following-the-guidelines
#3
JOURNAL ARTICLE
Hasan M Isa, Ahmed J Isa, Murtadha A Alnasheet, Mahmood M Mansoor
BACKGROUND: Fever is a common cause of medical consultation and hospital admission, particularly among children. Recently, the United Kingdom's National Institute for Health and Care Excellence (NICE) updated its guidelines for assessing fever in children under five years of age. The efficient assessment and management of children with fever are crucial for improving patient outcomes. AIM: To evaluate fever assessment in hospitalized children and to assess its adherence with the NICE Fever in under 5s guideline...
March 9, 2024: World Journal of Clinical Pediatrics
https://read.qxmd.com/read/38562131/mody-probability-calculator-is-suitable-for-mody-screening-in-china-a-population-based-study
#4
JOURNAL ARTICLE
Jing Zhao, Yan Chen, Fuhui Ma, Hua Shu, Li Zheng, Yang Liu, Xia Li, Tao Xu, Zhiguang Zhou, Kaixin Zhou
CONTEXT: Selecting appropriate individuals for genetic testing is essential due to the optimal treatment for maturity-onset diabetes of the young (MODY). However, how to effectively screen for MODY in China remains unclear. OBJECTIVE: To validate the performance of current screening strategies in selecting patients with MODY based on a nationwide type 2 diabetes cohort. METHODS: A panel of 14 MODY genes was analyzed from 1911 type 2 diabetes patients who were ages 15 to 35 years...
March 12, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38553272/upper-motor-neuron-assessment-in-amyotrophic-lateral-sclerosis-using-the-patellar-tendon-reflex-and-motor-evoked-potentials-to-the-lower-limbs
#5
JOURNAL ARTICLE
A Desmaison, A Truffert, B Pereira, J-P Camdessanché, X Moisset, N Guy
Amyotrophic lateral sclerosis (ALS) diagnosis relies on signs of progressive damage to both lower motoneuron (LMN), given by clinical examination and electromyography (EMG), and upper motoneuron (UMN), given by clinical examination only. Recognition of UMN involvement, however, is still difficult, so that diagnostic delay often remains too long. Shortening the time to clinical and genetic diagnosis is essential in order to provide accurate information to patients and families, avoid time-consuming investigations and for appropriate care management...
March 28, 2024: Revue Neurologique
https://read.qxmd.com/read/38551122/identification-of-fish-specimens-of-the-tocantins-river-brazil-using-dna-barcoding
#6
JOURNAL ARTICLE
Renato Corrêia Lima, Sabrina Rufino de Lima, Marcelo Salles Rocha, Hélio Daniel Beltrão Dos Anjos, Yasmin Catarina Alves Dantas, Ignácio Davi Navegante Benites, Cleonilde da Conceição Silva Queiroz, Elmary da Costa Fraga, Jacqueline da Silva Batista
The fish fauna of the Tocantins River possesses many endemic species; however, it is little studied in molecular terms and is quite threatened by the construction of several hydroelectric dams. Therefore, the objective of this study was to identify the ichthyofauna of the Tocantins River using DNA barcoding. For this, collections were carried out in five points of this river, which resulted in the capture of 725 individuals from which partial sequences of the cytochrome oxidase subunit I (COI) gene were obtained for genetic analysis...
March 29, 2024: Journal of Fish Biology
https://read.qxmd.com/read/38496304/preexisting-antibody-assays-for-gene-therapy-considerations-on-patient-selection-cutoffs-and-companion-diagnostic-requirements
#7
REVIEW
Manuela Braun, Claudia Lange, Philipp Schatz, Brian Long, Johannes Stanta, Boris Gorovits, Edit Tarcsa, Vibha Jawa, Tong-Yuan Yang, Wibke Lembke, Nicole Miller, Fraser McBlane, Louis Christodoulou, Daisy Yuill, Mark Milton
Recombinant adeno-associated virus (AAV) vectors are the leading delivery vehicle used for in vivo gene therapies. Anti-AAV antibodies (AAV Abs) can interact with the viral capsid component of an AAV-based gene therapy (GT). Therefore, patients with preexisting AAV Abs (seropositive patients) are often excluded from GT trials to prevent treatment of patients who are unlikely to benefit1 or may have a higher risk for adverse events outweighing treatment benefits. On the contrary, unnecessary exclusion of patients with high unmet medical need should be avoided...
March 14, 2024: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38472717/measuring-health-related-quality-of-life-in-children-with-suspected-genetic-conditions-validation-of-the-pedsql-proxy-report-versions
#8
JOURNAL ARTICLE
Hadley Stevens Smith, Michael Leo, Katrina Goddard, Kristin Muessig, Frank Angelo, Sara Knight, Simon Outram, Nicole R Kelly, Christine Rini
PURPOSE: Measuring health-related quality of life (HRQoL) of children with suspected genetic conditions is important for understanding the effect of interventions such as genomic sequencing (GS). The Pediatric Quality of Life Inventory (PedsQL) is a widely used generic measure of HRQoL in pediatric patients, but its psychometric properties have not yet been evaluated in children undergoing diagnostic GS. METHODS: In this cross-sectional study, we surveyed caregivers at the time of their child's enrollment into GS research studies as part of the Clinical Sequencing Evidence Generating Research (CSER) consortium...
March 12, 2024: Quality of Life Research
https://read.qxmd.com/read/38455728/towards-a-practical-threat-assessment-methodology-for-crop-landraces
#9
JOURNAL ARTICLE
Maria João Almeida, Ana Maria Barata, Stef De Haan, Bal Krishna Joshi, Joana Magos Brehm, Mariana Yazbek, Nigel Maxted
Crop landraces (LR), the traditional varieties of crops that have been maintained for millennia by repeated cycles of planting, harvesting, and selection, are genetically diverse compared to more modern varieties and provide one of the key components for crop improvement due to the ease of trait transfer within the crop species. However, LR diversity is increasingly threatened with genetic erosion and extinction by replacement with improved cultivars, lack of incentives for farmers to maintain traditional agricultural systems, and rising threats from climate change...
2024: Frontiers in Plant Science
https://read.qxmd.com/read/38409289/evidence-review-and-considerations-for-use-of-first-line-genome-sequencing-to-diagnose-rare-genetic-disorders
#10
REVIEW
Kristen M Wigby, Deanna Brockman, Gregory Costain, Caitlin Hale, Stacie L Taylor, John Belmont, David Bick, David Dimmock, Susan Fernbach, John Greally, Vaidehi Jobanputra, Shashikant Kulkarni, Elizabeth Spiteri, Ryan J Taft
Early use of genome sequencing (GS) in the diagnostic odyssey can reduce suffering and improve care, but questions remain about which patient populations are most amenable to GS as a first-line diagnostic test. To address this, the Medical Genome Initiative conducted a literature review to identify appropriate clinical indications for GS. Studies published from January 2011 to August 2022 that reported on the diagnostic yield (DY) or clinical utility of GS were included. An exploratory meta-analysis using a random effects model evaluated DY based on cohort size and diagnosed cases per cohort...
February 26, 2024: NPJ Genomic Medicine
https://read.qxmd.com/read/38398443/the-dizzyquest-combined-with-accelerometry-daily-physical-activities-and-limitations-among-patients-with-bilateral-vestibulopathy-due-to-dfna9
#11
JOURNAL ARTICLE
Erik Martin, Sofie de Hoon, Joost Stultiens, Miranda Janssen, Hans Essers, Kenneth Meijer, Wouter Bijnens, Maurice van de Berg, Nolan Herssens, Sebastien Janssens de Varebeke, Ann Hallemans, Vincent Van Rompaey, Nils Guinand, Angelica Perez-Fornos, Josine Widdershoven, Raymond van de Berg
BACKGROUND: DFNA9 is a genetic disease of the inner ear, causing progressive bilateral sensorineural deafness and bilateral vestibulopathy (BV). In this study, DizzyQuest, a mobile vestibular diary, and the MOX accelerometer were combined to assess the daily life functional limitations and physical activity of patients with DFNA9 suffering from BV. These parameters might be appropriate as potential candidacy criteria and outcome measures for new therapeutic interventions for BV. METHODS: Fifteen DFNA9 patients with BV and twelve age-matched healthy controls were included...
February 17, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38337803/somatic-mutations-in-latin-american-breast-cancer-patients-a-systematic-review-and-meta-analysis
#12
REVIEW
Gabriela A Martínez-Nava, Laura Keren Urbina-Jara, Saúl Lira-Albarrán, Henry L Gómez, Erika Ruiz-García, María Tereza Nieto-Coronel, Rocio Ortiz-Lopez, Kenia Nadiezhda Martínez Villalba, Mariana Muñoz-Sánchez, Dione Aguilar, Liliana Gómez-Flores-Ramos, Sara Aileen Cabrera-Nieto, Alejandro Mohar, Marlid Cruz-Ramos
(1) Background: Somatic mutations may be connected to the exposome, potentially playing a role in breast cancer's development and clinical outcomes. There needs to be information regarding Latin American women specifically, as they are underrepresented in clinical trials and have limited access to somatic analysis in their countries. This study aims to systematically investigate somatic mutations in breast cancer patients from Latin America to gain a better understanding of tumor biology in the region. (2) Methods: We realize a systematic review of studies on breast cancer in 21 Latin American countries using various databases such as PubMed, Google Scholar, Web of Science, RedAlyc, Dianlet, and Biblioteca Virtual en Salud...
January 29, 2024: Diagnostics
https://read.qxmd.com/read/38312664/mapping-covid-19-s-potential-infection-risk-based-on-land-use-characteristics-a-case-study-of-commercial-activities-in-two-egyptian-cities
#13
JOURNAL ARTICLE
Karim I Abdrabo, Mahmoud Mabrouk, Haoying Han, Mohamed Saber, Sameh A Kantoush, Tetsuya Sumi
The contagious COVID-19 has recently emerged and evolved into a world-threatening pandemic outbreak. After pursuing rigorous prophylactic measures two years ago, most activities globally reopened despite the emergence of lethal genetic strains. In this context, assessing and mapping activity characteristics-based hot spot regions facilitating infectious transmission is essential. Hence, our research question is: How can the potential hotspots of COVID-19 risk be defined intra-cities based on the spatial planning of commercial activity in particular? In our research, Zayed and October cities, Egypt, characterized by various commercial activities, were selected as testbeds...
January 30, 2024: Heliyon
https://read.qxmd.com/read/38311346/splicing-analysis-of-24-potential-spliceogenic-variants-in-mmr-genes-and-clinical-interpretation-based-on-refined-acmg-amp-criteria
#14
JOURNAL ARTICLE
Ahmed Bouras, Cedrick Lefol, Eric Ruano, Chloé Grand-Masson, Jessie Auclair-Perrossier, Qing Wang
Lynch syndrome (LS) is a common hereditary cancer syndrome caused by heterozygous germline pathogenic variants in DNA mismatch repair (MMR) genes. Splicing defect constitutes one of the major mechanisms for MMR gene inactivation. Using RT-PCR based RNA analysis, we investigated 24 potential spliceogenic variants in MMR genes and determined their pathogenicity based on refined splicing-related American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) criteria. Aberrant transcripts were confirmed in 19 variants and 17 of which were classified as pathogenic including 11 located outside of canonical splice sites...
February 4, 2024: Human Molecular Genetics
https://read.qxmd.com/read/38287743/genetic-testing-for-familial-melanoma
#15
JOURNAL ARTICLE
Clare A Primiero, Ellie J Maas, Courtney K Wallingford, H Peter Soyer, Aideen M McInerney-Leo
While the average lifetime risk of melanoma worldwide is approximately 3%, those with inherited high-penetrance mutations face an increased lifetime risk of 52-84%. In countries of low melanoma incidence, such as in Southern Europe, familial melanoma genetic testing may be warranted when there are two first degree relatives with a melanoma diagnosis. Testing criteria for high incidence countries such as USA, or with very-high incidence, such as Australia and New Zealand, would require a threshold of 3 to 4 affected family members...
January 29, 2024: Italian journal of dermatology and venereology
https://read.qxmd.com/read/38245954/investigating-the-association-of-previously-identified-genome-wide-significant-loci-rs10739076-and-rs1784692-with-pcos-susceptibility-and-its-related-traits-in-indian-women
#16
JOURNAL ARTICLE
Roshan Dadachanji, Sushma Khavale, Anushree Patil, Srabani Mukherjee
OBJECTIVE(S): Polycystic ovary syndrome (PCOS) is a multifactorial endocrinopathy with an enigmatic etiology. Hallmark features include irregular menstrual cycles, insulin resistance and hyperandrogenemia and affected women are prone to development of adverse reproductive and cardiometabolic outcomes like anovulatory infertility, impaired glucose tolerance, type 2 diabetes, dyslipidemia, metabolic syndrome and cardiovascular disease. Genetic underpinnings of PCOS have been investigated extensively using genome-wide association studies, which have led to the identification of several novel susceptibility loci...
January 17, 2024: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://read.qxmd.com/read/38228467/using-implementation-science-to-develop-a-familial-hypercholesterolemia-screening-program-in-primary-care-the-care-fh-study
#17
JOURNAL ARTICLE
Laney K Jones, Katrina M Romagnoli, Tyler J Schubert, Katarina Clegg, H Lester Kirchner, Yirui Hu, Dylan Cawley, Victoria Norelli, Marc S Williams, Samuel S Gidding, Alanna K Rahm
BACKGROUND: We designed the Collaborative Approach to Reach Everyone with familial hypercholesterolemia (CARE-FH) clinical trial to improve FH screening in primary care and facilitate guideline-based care. OBJECTIVE: The goal was to incorporate perspectives from end-users (healthcare system leaders, primary care clinicians, cardiologists, genetic counselors, nurses, and clinic staff) and improve translation of screening guidance into practice. METHODS: We partnered with end-users to sequentially define the current state of FH screening, assess acceptability, feasibility, and appropriateness of implementing an FH screening program, and select clinically actionable strategies at the patient-, clinician-, and system-level to be deployed as a package in the CARE-FH clinical trial...
January 4, 2024: Journal of Clinical Lipidology
https://read.qxmd.com/read/38204740/diagnosis-and-assessment-of-autism-spectrum-disorder-in-south-korea
#18
JOURNAL ARTICLE
Johanna Inhyang Kim, Hee Jeong Yoo
Autism spectrum disorder (ASD) is diagnosed by the clinical decision of a trained professional based on the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition or International Classification of Diseases 11th Revision diagnostic criteria. To obtain information for diagnostic formulation, professionals should explore detailed developmental history, and can use structured or semi-structured assessment tools to observe interaction between the child and parents or strangers. Diagnostic assessment should include a profile of the strength and weaknesses of the individual and should be conducted using an optimal approach by a multidisciplinary team with appropriate techniques and experience...
January 1, 2024: Soa--chʻŏngsonyŏn chŏngsin ŭihak, Journal of child & adolescent psychiatry
https://read.qxmd.com/read/38199457/evaluating-clingen-variant-curation-expert-panels-application-of-pvs1-code
#19
JOURNAL ARTICLE
Xiaoyan Wang, Haibo Li, Haiyan Luo, Yongyi Zou, Haoxian Li, Yayun Qin, Jieping Song
BACKGROUND: The 2015 American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines articulates that the effects of certain types of variants on gene function can often be seen as a complete absence of the gene product by leading to a lack of transcription or nonsense-mediated decay(NMD). However, detailed information considering different types of loss of function(LOF) variants, refined steps assimilating details concerning location of variant, changes in strength levels, NMD boundary, or any additional information pointing to a true null effect, were all left to expert judgement...
January 8, 2024: European Journal of Medical Genetics
https://read.qxmd.com/read/38127222/performance-evaluate-of-different-chemometrics-formalisms-used-for-prostate-cancer-diagnosis-by-nmr-based-metabolomics
#20
JOURNAL ARTICLE
Márcio Felipe Oliveira, Moacir Cavalcante de Albuquerque Neto, Thiago Siqueira Leite, Paulo André Araújo Alves, Salvador Vilar Correia Lima, Ricardo Oliveira Silva
INTRODUCTION: In general, two characteristics are ever present in NMR-based metabolomics studies: (1) they are assays aiming to classify the samples in different groups, and (2) the number of samples is smaller than the feature (chemical shift) number. It is also common to observe imbalanced datasets due to the sampling method and/or inclusion criteria. These situations can cause overfitting. However, appropriate feature selection and classification methods can be useful to solve this issue...
December 21, 2023: Metabolomics: Official Journal of the Metabolomic Society
keyword
keyword
167748
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.